These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 8093890

  • 1. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A, Jin X, Sissons P, Borysiewicz L.
    J Exp Med; 1993 Feb 01; 177(2):249-56. PubMed ID: 8093890
    [Abstract] [Full Text] [Related]

  • 2. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK, Merigan TC.
    AIDS; 1992 Jul 01; 6(7):643-9. PubMed ID: 1354446
    [Abstract] [Full Text] [Related]

  • 3. Cytotoxic T lymphocyte response against multiple simian immunodeficiency virusA (SIV) proteins in SIV-infected macaques.
    Venet A, Bourgault I, Aubertin AM, Kiény MP, Levy JP.
    J Immunol; 1992 May 01; 148(9):2899-908. PubMed ID: 1349322
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Virus-specific cytotoxic T-lymphocytes in HIV-2-infected cynomolgus macaques.
    Voss G, Nick S, Otteken A, Lüke W, Stahl-Hennig C, Hunsmann G.
    AIDS; 1992 Oct 01; 6(10):1077-83. PubMed ID: 1466839
    [Abstract] [Full Text] [Related]

  • 6. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities.
    Koup RA, Pikora CA, Luzuriaga K, Brettler DB, Day ES, Mazzara GP, Sullivan JL.
    J Exp Med; 1991 Dec 01; 174(6):1593-600. PubMed ID: 1744586
    [Abstract] [Full Text] [Related]

  • 7. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes.
    Lubaki MN, Egan MA, Siliciano RF, Weinhold KJ, Bollinger RC.
    AIDS Res Hum Retroviruses; 1994 Nov 01; 10(11):1427-31. PubMed ID: 7888197
    [Abstract] [Full Text] [Related]

  • 8. High frequency of Gag- and envelope-specific cytotoxic T lymphocyte precursors in children with vertically acquired human immunodeficiency virus type 1 infection.
    McFarland EJ, Harding PA, Luckey D, Conway B, Young RK, Kuritzkes DR.
    J Infect Dis; 1994 Oct 01; 170(4):766-74. PubMed ID: 7930716
    [Abstract] [Full Text] [Related]

  • 9. HIV-specific cytotoxic T-lymphocyte activity in immunologically normal HIV-infected persons.
    Bernard NF, Pederson K, Chung F, Ouellet L, Wainberg MA, Tsoukas CM.
    AIDS; 1998 Nov 12; 12(16):2125-39. PubMed ID: 9833853
    [Abstract] [Full Text] [Related]

  • 10. A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction.
    Beatty JA, Willett BJ, Gault EA, Jarrett O.
    J Virol; 1996 Sep 12; 70(9):6199-206. PubMed ID: 8709246
    [Abstract] [Full Text] [Related]

  • 11. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
    Ahearne PM, Morgan RA, Sebastian MW, Bolognesi DP, Weinhold KJ.
    Cell Immunol; 1995 Mar 12; 161(1):34-41. PubMed ID: 7867083
    [Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus type 1 (HIV-1)--and Epstein-Barr virus--specific cytotoxic T lymphocyte precursors exhibit different kinetics in HIV-1--infected persons.
    Geretti AM, Dings ME, van Els CA, van Baalen CA, Wijnholds FJ, Borleffs JC, Osterhaus AD.
    J Infect Dis; 1996 Jul 12; 174(1):34-45. PubMed ID: 8656011
    [Abstract] [Full Text] [Related]

  • 13. Analysis of the human env-specific cytotoxic T-lymphocyte (CTL) response in natural human immunodeficiency virus type 1 infection: low prevalence of broadly cross-reactive env-specific CTL.
    Carmichael A, Jin X, Sissons P.
    J Virol; 1996 Dec 12; 70(12):8468-76. PubMed ID: 8970969
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal study of HIV-specific cytotoxic lymphocytes in HIV type 1-infected patients: relative balance between host immune response and the spread of HIV type 1 infection.
    Bariou C, Genetet N, Ruffault A, Michelet C, Cartier F, Genetet B.
    AIDS Res Hum Retroviruses; 1997 Oct 10; 13(15):1301-12. PubMed ID: 9339847
    [Abstract] [Full Text] [Related]

  • 15. Anti-HIV type 1 cytotoxic T lymphocyte effector activity and disease progression in the first 8 years of HIV type 1 infection of homosexual men.
    Rinaldo CR, Beltz LA, Huang XL, Gupta P, Fan Z, Torpey DJ.
    AIDS Res Hum Retroviruses; 1995 Apr 10; 11(4):481-9. PubMed ID: 7632463
    [Abstract] [Full Text] [Related]

  • 16. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.
    Lucchiari M, Niedermann G, Leipner C, Meyerhans A, Eichmann K, Maier B.
    Int Immunol; 1994 Nov 10; 6(11):1739-49. PubMed ID: 7865467
    [Abstract] [Full Text] [Related]

  • 17. Recognition patterns of HLA-A2-restricted human immunodeficiency virus-1-specific cytotoxic T-lymphocytes in a cohort of HIV-1-infected individuals.
    Schmitt-Haendle M, Bachmann O, Harrer E, Schmidt B, Bäuerle M, Harrer T.
    Viral Immunol; 2005 Nov 10; 18(4):627-36. PubMed ID: 16359229
    [Abstract] [Full Text] [Related]

  • 18. The influence of lymphocyte counts and disease progression on circulating and inducible anti-HIV-1 cytotoxic T-cell activity in HIV-1-infected subjects.
    Grant MD, Smaill FM, Singal DP, Rosenthal KL.
    AIDS; 1992 Oct 10; 6(10):1085-94. PubMed ID: 1361339
    [Abstract] [Full Text] [Related]

  • 19. Cytotoxic T-lymphocytes that kill autologous CD4+ lymphocytes are associated with CD4+ lymphocyte depletion in HIV-1 infection.
    Grant MD, Smail FM, Rosenthal KL.
    J Acquir Immune Defic Syndr (1988); 1994 Jun 10; 7(6):571-9. PubMed ID: 7909845
    [Abstract] [Full Text] [Related]

  • 20. Multiple subsets of HIV-specific cytotoxic T lymphocytes in humans and in mice.
    Chenciner N, Michel F, Dadaglio G, Langlade-Demoyen P, Hoffenbach A, Leroux A, Garcia-Pons F, Rautmann G, Guy B, Guillon JM.
    Eur J Immunol; 1989 Sep 10; 19(9):1537-44. PubMed ID: 2676560
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.